Literature DB >> 19520559

Yellow fever vaccine - how does it work and why do rare cases of serious adverse events take place?

Alan D T Barrett1, Dirk E Teuwen.   

Abstract

Yellow fever 17D vaccine is one of the most successful vaccines ever developed and over 540 million doses have been used. Nevertheless there has been very little known about the mechanism of protection induced by the vaccine. The last couple of years have seen important advances made in understanding how the vaccine works involving studies of the innate and adaptive immune responses plus a systems biology approach. Like all vaccines, the 17D vaccine causes rare serious adverse events (SAEs) following immunization. At present, the mechanism(s) of SAEs is(are) poorly understood but our advances in understanding the immune response induced by the vaccine have promise to help elucidate the mechanism of SAEs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19520559     DOI: 10.1016/j.coi.2009.05.018

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  71 in total

Review 1.  Vaccine and adjuvant design for emerging viruses: mutations, deletions, segments and signaling.

Authors:  Gavin C Bowick; Alexander J McAuley
Journal:  Bioeng Bugs       Date:  2011-05-01

2.  Mapping the risk of yellow Fever infection.

Authors:  David R Hill
Journal:  Curr Infect Dis Rep       Date:  2012-06       Impact factor: 3.725

3.  NIAID workshop on Flavivirus immunity.

Authors:  Alison D Augustine; M Cristina Cassetti; Francis A Ennis; Eva Harris; William H Hildebrand; Patricia M Repik
Journal:  Viral Immunol       Date:  2010-06       Impact factor: 2.257

4.  Stability of RNA virus attenuation approaches.

Authors:  Joan L Kenney; Sara M Volk; Jyotsna Pandya; Eryu Wang; Xiaodong Liang; Scott C Weaver
Journal:  Vaccine       Date:  2011-02-01       Impact factor: 3.641

5.  Nucleoside Analogs with Antiviral Activity against Yellow Fever Virus.

Authors:  Keivan Zandi; Franck Amblard; Sarah Amichai; Leda Bassit; Sijia Tao; Yong Jiang; Longhu Zhou; Olivia Ollinger Russell; Seema Mengshetti; Raymond F Schinazi
Journal:  Antimicrob Agents Chemother       Date:  2019-08-23       Impact factor: 5.191

Review 6.  Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology.

Authors:  Bali Pulendran
Journal:  Nat Rev Immunol       Date:  2009-09-18       Impact factor: 53.106

7.  Molecular and immunological characterization of a DNA-launched yellow fever virus 17D infectious clone.

Authors:  Xiaohong Jiang; Tim J Dalebout; Igor S Lukashevich; Peter J Bredenbeek; David Franco
Journal:  J Gen Virol       Date:  2014-12-16       Impact factor: 3.891

Review 8.  Vaccination strategies against Zika virus.

Authors:  Estefania Fernandez; Michael S Diamond
Journal:  Curr Opin Virol       Date:  2017-04-19       Impact factor: 7.090

9.  Persistence of Yellow Fever vaccine-induced antibodies after cord blood stem cell transplant.

Authors:  Vivian Iida Avelino-Silva; Marcos da Silva Freire; Vanderson Rocha; Celso Arrais Rodrigues; Yana Sarkis Novis; Ester C Sabino; Esper Georges Kallas
Journal:  Hum Vaccin Immunother       Date:  2015-11-30       Impact factor: 3.452

Review 10.  Comparative pathogenesis and systems biology for biodefense virus vaccine development.

Authors:  Gavin C Bowick; Alan D T Barrett
Journal:  J Biomed Biotechnol       Date:  2010-06-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.